Suppr超能文献

针对抑制猿猴病毒40和人类多瘤病毒感染的化学物质进行的基于细胞的高通量筛选。

High-throughput cell-based screen for chemicals that inhibit infection by simian virus 40 and human polyomaviruses.

作者信息

Goodwin Edward C, Atwood Walter J, DiMaio Daniel

机构信息

Department of Genetics, Yale University School of Medicine, New Haven, Connecticut 06520-8005, USA.

出版信息

J Virol. 2009 Jun;83(11):5630-9. doi: 10.1128/JVI.00203-09. Epub 2009 Mar 18.

Abstract

We developed a high-throughput, cell-based screen to identify chemicals that inhibit infection by the primate polyomaviruses. The screen is based on the detection of compounds that inhibit the ability of a replication-defective simian virus 40 (SV40)-based viral vector to cause growth arrest in HeLa cells by repressing the expression of the endogenous human papillomavirus E7 oncogene in these cells. We identified two compounds, ellagic acid and spiperone, that suppressed the ability of the SV40 recombinant virus to inhibit cellular DNA synthesis. These compounds caused a marked reduction of the ability of wild-type SV40 to productively infect permissive monkey cells, even when the compounds were added several hours after infection. The fraction of cells expressing SV40 large T antigen and the levels of T antigen mRNA were reduced in infected human and monkey cells treated with ellagic acid and spiperone, suggesting that these compounds block a step in the virus life cycle prior to SV40 early gene expression. Ellagic acid and spiperone also inhibited large T antigen expression by BK virus and JC virus, two important, pathogenic human polyomaviruses.

摘要

我们开发了一种基于细胞的高通量筛选方法,以鉴定能够抑制灵长类多瘤病毒感染的化学物质。该筛选方法基于对化合物的检测,这些化合物通过抑制内源性人乳头瘤病毒E7癌基因在HeLa细胞中的表达,来抑制基于复制缺陷型猿猴病毒40(SV40)的病毒载体导致HeLa细胞生长停滞的能力。我们鉴定出两种化合物,鞣花酸和螺哌隆,它们可抑制SV40重组病毒抑制细胞DNA合成的能力。即使在感染数小时后添加这些化合物,它们也能显著降低野生型SV40有效感染允许性猴细胞的能力。在用鞣花酸和螺哌隆处理的受感染人和猴细胞中,表达SV40大T抗原的细胞比例以及T抗原mRNA水平均降低,这表明这些化合物在SV40早期基因表达之前阻断了病毒生命周期中的一个步骤。鞣花酸和螺哌隆还抑制了BK病毒和JC病毒(两种重要的致病性人类多瘤病毒)的大T抗原表达。

相似文献

1
High-throughput cell-based screen for chemicals that inhibit infection by simian virus 40 and human polyomaviruses.
J Virol. 2009 Jun;83(11):5630-9. doi: 10.1128/JVI.00203-09. Epub 2009 Mar 18.
3
A comparison of human papovavirus T antigens.
J Gen Virol. 1976 Oct;33(1):61-70. doi: 10.1099/0022-1317-33-1-61.
5
Activities of various compounds against murine and primate polyomaviruses.
Antimicrob Agents Chemother. 1997 Mar;41(3):587-93. doi: 10.1128/AAC.41.3.587.
6
Simian virus 40 DNA replication in vitro: specificity of initiation and evidence for bidirectional replication.
Mol Cell Biol. 1985 Jun;5(6):1238-46. doi: 10.1128/mcb.5.6.1238-1246.1985.
8
Antiviral activity of pyrrole-imidazole polyamides against SV40 and BK polyomaviruses.
Antiviral Res. 2018 Apr;152:68-75. doi: 10.1016/j.antiviral.2018.02.012. Epub 2018 Feb 16.

引用本文的文献

3
Endoplasmic reticulum secretory pathway: Potential target against SARS-CoV-2.
Virus Res. 2022 Oct 15;320:198897. doi: 10.1016/j.virusres.2022.198897. Epub 2022 Aug 18.
4
Effect of Ellagic Acid on Seizure Threshold in Two Acute Seizure Tests in Mice.
Molecules. 2021 Aug 10;26(16):4841. doi: 10.3390/molecules26164841.
5
Search, Identification, and Design of Effective Antiviral Drugs Against Pandemic Human Coronaviruses.
Adv Exp Med Biol. 2021;1322:219-260. doi: 10.1007/978-981-16-0267-2_9.
6
Recent advances in developing small-molecule inhibitors against SARS-CoV-2.
Acta Pharm Sin B. 2022 Apr;12(4):1591-1623. doi: 10.1016/j.apsb.2021.06.016. Epub 2021 Jul 2.
7
Neuroprotective Potential of Ellagic Acid: A Critical Review.
Adv Nutr. 2021 Jul 30;12(4):1211-1238. doi: 10.1093/advances/nmab007.
9
Antioxidative Action of Ellagic Acid-A Kinetic DFT Study.
Antioxidants (Basel). 2020 Jul 6;9(7):587. doi: 10.3390/antiox9070587.

本文引用的文献

1
Early events during BK virus entry and disassembly.
J Virol. 2009 Feb;83(3):1350-8. doi: 10.1128/JVI.02169-08. Epub 2008 Nov 26.
4
Clonal integration of a polyomavirus in human Merkel cell carcinoma.
Science. 2008 Feb 22;319(5866):1096-100. doi: 10.1126/science.1152586. Epub 2008 Jan 17.
5
Progressive multifocal leucoencephalopathy in a patient with systemic lupus erythematosus treated with rituximab.
Rheumatology (Oxford). 2008 Feb;47(2):224-5. doi: 10.1093/rheumatology/kem299. Epub 2007 Nov 28.
7
Polyomavirus BK infection in blood and marrow transplant recipients.
Bone Marrow Transplant. 2008 Jan;41(1):11-8. doi: 10.1038/sj.bmt.1705886. Epub 2007 Oct 22.
8
BK virus nephropathy and kidney transplantation.
Clin J Am Soc Nephrol. 2007 Jul;2 Suppl 1:S36-46. doi: 10.2215/CJN.00920207.
9
Identification of a novel polyomavirus from patients with acute respiratory tract infections.
PLoS Pathog. 2007 May 4;3(5):e64. doi: 10.1371/journal.ppat.0030064.
10
Reactivation of JC virus and development of PML in patients with multiple sclerosis.
Neurology. 2007 Mar 27;68(13):985-90. doi: 10.1212/01.wnl.0000257832.38943.2b.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验